It is available in form of tablets. Adequate and strictly controlled studies on over the counter of the use of ivermectin during pregnancy have not been conducted. It is not known whether the drug has immediate or delayed adverse effects on the fetus.

After oral administration, low concentrations of ivermectin are excreted into breast milk. When applied topically, the release of ivermectin into breast milk has not been studied.

The most common adverse reactions, such as burning sensation, skin irritation, itching and dry skin, were reported in less than 1% of patients.